Clincosm LogoSign in Get a demo

thrombosis

Showing NaN - NaN of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thrombosis Trial in Worldwide (Apixaban, Vitamin K Antagonist (VKA), Low Molecular Weight Heparin (LMWH))

Completed
Has Results
  • Thrombosis
  • Phoenix, Arizona
  • +45 more
Sep 29, 2022

Covid19, Thrombosis Trial in Spain (Tinzaparin)

Completed
  • Covid19
  • Thrombosis
  • A Coruña, Spain
  • +17 more
Sep 13, 2022

Catheter Occlusion, Thrombosis Trial in Worldwide (CUSA-081, Placebo, Alteplase)

Recruiting
  • Catheter Occlusion
  • Thrombosis
  • Little Rock, Arkansas
  • +76 more
Mar 29, 2022

Thromboprophylaxis for Patients in ICU With COVID-19

Completed
  • Covid19
  • +2 more
    • Zaragoza, Aragón, Spain
    • +30 more
    Mar 29, 2022

    Thrombosis Trial in Worldwide (Rivaroxaban, Acetylsalicylic Acid)

    Completed
    Has Results
    • Thrombosis
    • Los Angeles, California
    • +41 more
    Mar 2, 2022

    Thrombosis Trial in Worldwide (Rivaroxaban (Xarelto, BAY59-7939)

    Completed
    • Thrombosis
    • Rivaroxaban (Xarelto, BAY59-7939
    • Little Rock, Arkansas
    • +20 more
    Apr 14, 2019

    Embolism, Thrombosis Trial in Worldwide (Idrabiotaparinux sodium, Warfarin, Placebo (for idrabiotaparinux sodium))

    Completed
    • Embolism
    • Thrombosis
    • Idrabiotaparinux sodium
    • +5 more
    • Bridgewater, New Jersey
    • +37 more
    Feb 19, 2016

    Cancer, Thrombosis Trial in Romania, Spain (Bemiparin, Placebo)

    Terminated
    • Cancer
    • Thrombosis
    • Arad, Romania
    • +18 more
    Jun 7, 2012

    Diagnostic Approach of Deep Vein Thrombosis in Primary Care

    Unknown status
    • Thrombosis
    • D Dimer and ultrasonography
    • Barcelona, Spain
      Hospital Santa Creu i Sant Pau
    May 8, 2012

    Thrombosis, Anticoagulant-induced Bleeding, Anticoagulant Overdosage Trial in Barcelona (Rivaroxaban, Dabigatran)

    Unknown status
    • Thrombosis
    • +3 more
    • Barcelona, Spain
      Hospital Clinic, Fundació Clinic (FCRB)
    Mar 9, 2012